IT ATC L04AB06 · updated 2 Nov 2026
Golimumab shortage in Italy
Is there a Golimumab shortage in Italy?
Yes. As of 2 Nov 2026, 1 Golimumab product is reported short in Italy. The company estimate for the return is 20 Feb 2027. Main reason: increased demand.
Also short in Germany, Belgium, Sweden, Japan. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | GOBIVAZ anticipated | ADVANZ PHARMA LIMITED | 1 Dec 2026 | 20 Feb 2027 | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.